Back
Photronics 10K Form
Sell
48
PLAB
Photronics
Last Price:
$24.16
Seasonality Move:
8.34%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-06-07 | 10Q | PLAB/Photronics Quarterly |
2024-03-07 | 10Q | PLAB/Photronics Quarterly |
2023-09-07 | 10Q | PLAB/Photronics Quarterly |
2023-06-08 | 10Q | PLAB/Photronics Quarterly |
2023-03-09 | 10Q | PLAB/Photronics Quarterly |
2022-09-07 | 10Q | PLAB/Photronics Quarterly |
Receive PLAB News And Ratings
See the #1 stock for the next 7 days that we like better than PLAB
PLAB Financial Statistics
Sales & Book Value
Annual Sales: | $866.9M |
---|---|
Cash Flow: | $25.1M |
Price / Cash Flow: | 11.41 |
Annual Sales: | $18.09 |
Price / Book: | 1.35 |
Profitability
EPS (TTM): | 2.09000 |
---|---|
Net Income (TTM): | $130.7M |
Gross Margin: | $315.9M |
Return on Equity: | 9.49% |
Return on Assets: | 8.1% |
Photronics Earnings Forecast
Key Photronics Financial Ratios
-
The Gross Profit Margin over the past 40 years for PLAB is 36.44%.
-
The Selling, General & Administrative Expenses for PLAB have been equal to 8.97% of Gross Profit Margin.
-
The Research & Development expenses have been 1.91% of Revenue.
-
The Interest Expense is 0.26% of Operating Income.
-
The Net Earning history of PLAB is 15.07% of Total Revenues.
-
Per Share Earnings over the last 41 years have been positive in 22 years.
Photronics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Semiconductors & Semiconductor Equipment |
Sector: | Information Technology |
Current Symbol: | PLAB |
CUSIP: | 719405 |
Website: | photronics.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 5.07 |
Quick Ratio: | 4.68 |
Price-to-Earnings
Trailing P/E Ratio: | 11.41 |
---|---|
Forward P/E Ratio: | 10.37 |
PLAB Technical Analysis vs Fundamental Analysis
Sell
48
Photronics (PLAB)
is a Sell
Is Photronics a Buy or a Sell?
-
Photronics stock is rated a SellThe current Photronics [PLAB] share price is $23.85. The Score for PLAB is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.